can catalyze the hydrolysis of the R-O-glycosidic linkage
of N-acetylneuraminic acid (NeuAc, 1) connected to a variety
of aglycons on the cellular surface.10 We have tried to
synthesize N-acetylneuraminic acid-NO donor conjugates
as novel NO prodrugs targeting influenza viruses. If these
NO donors could bind and be hydrolyzed by influenza
neuraminidases, the NO will be released around viruses and
obtain the targeting effect. Our proposed synthetic NeuAc-
NO conjugates can also be used as probes to selectively
deliver NO to viruses. Such conjugates may also be used to
test a neuraminidase-activated prodrug design for antiviral
therapy.
different pH. Compound 5 was very stable in both neutral
and basic (pH 10, NaOH) solution and did not decompose
within several days, while in acidic (pH 1, HCl) solution it
showed a half-life about 19.6 h. Additionally, this compound
decomposed readily after addition of neuraminidase (EC
3.2.1.18, from Clostridium perfringens, Sigma). The decom-
position went steadily, as determined by the decay of the
absorbance at 255 nm (Figure 1). The enzymatic kinetics
PYRRO/NO (3), which has a half-life about 3 s, was
chosen as a representative of diazeniumdiolates.11 N-Acetyl-
neuraminyl chloride (2), which was prepared from N-
acetylneuraminic acid (1), was utilized as the sialadation
donor. Acetonitrile was used as the solvent for the reaction,
since it is an excellent solvent to obtain the R-anomer.
Compound 2 was stirred with 3 in anhydrous acetonitrile at
room temperature. The reaction was monitored by TLC. After
2 days, the starting material totally disappeared and there
was one product shown on TLC. After column chromatog-
raphy on silica gel, the R-anomer of sialyl diazeniumdiolate
(4) was obtained in 70% yield (Scheme 1). Since the
Scheme 1
Figure 1. UV absorbance changing of 5 in the presence (O) and
in the absence (b) of neuraminidase. Neuraminidase (0.05 mg/mL)
and 5 (0.15 mM) were incubated in 150 mM phosphate buffer, pH
7.4, 37 °C. UV was measured at 255 nm.
were measured on a UV-vis spectrophotometer fitted with
an electrically thermostated cell block. The Michaelis
constant (Km) was determined from the Lineweaver-Burk
plot. The Km (0.14 mM) was smaller than Km values (0.6-
1.6 mM) for oligosaccharides as substrates,14 which indicated
the binding between 5 and neuraminidase was stronger than
the natural sialosides. The kcat was calculated as 1.92 s-1,
revealing that the enzymatic hydrolysis was efficient.
The enzymatic decomposition of 5 was also examined by
NO measurement. The amount of NO generated could be
measured with an electrochemical ISO-NO Mark-II isolated
nitric oxide meter (World Precision Instruments, Inc. Sara-
sota, Florida). As shown in Figure 2, 5 was stable in the
buffer solution (pH 5.0), whereas a substantial amount of
NO was generated after the addition of neuraminidase. The
NO released from PYRRO/NO could not be shown in Figure
2, since its half-life is only 2.8 s, and the NO signal
disappeared within 30 s. In aerobic solution, NO is released
but it is consumed by the NO/O2 reaction and dissipates by
diffusion from the solutions. This is the reason that only a
small amount of NO was detected. In addition, the Griess
method15 also showed the formation of nitrite ion from the
enzymatic decomposition of 5, because the NO was oxidized
R-anomer is thermodynamically disfavored and there is no
suitable neighboring participation at C-3, it would be difficult
to control the anomeric selectivity. However, the result came
out successfully. The reason might be the formation of
â-acetonitrilium ion as an intermediate which provides
predominantly R-sialosides.12 Then deprotection of the acetyl
and ester groups afforded the first sialated diazeniumdiolate
(5). The anomeric configuration was determined as R by the
chemical shift of H3e (2.70 ppm).13
This novel NO donor (5) was water-soluble and very stable
in the solid state. It could be stored at room temperature
without any decomposition for months. The stability of this
novel NO donor was tested in aqueous solutions with
(10) Air, G. M.; Laver, W. G. Proteins 1989, 6, 341.
(11) Saavedra, J. E.; Billiar, T. R.; Williams, D. L.; Kim, Y.-M.; Watkins,
S. C.; Keefer, L. K. J. Med. Chem. 1997, 40, 1947.
(12) Nicolaou, K. C.; Hummel, C. W.; Bockovich, N. J.; Wong, C.-H.
J. Chem. Soc., Chem. Commun. 1991, 870.
(14) Bouwstra, J. B.; Deyl, C. M.; Vliegenthart, J. F. G. Biol. Chem.
Hoppe-Seyler 1987, 368, 269.
(13) Dabrowski, U.; Friebolin, R.; Brossmer, R.; Supp, M. Tetahedron
Lett. 1979, 4637.
(15) Green, L. C.; Wagner, D. A.; Glogowski, J.; Skipper, P. L.; Wishnok,
J. S.; Tannenbaum, S. R. Anal. Biochem. 1982, 126, 131.
4204
Org. Lett., Vol. 6, No. 23, 2004